Institute of Advanced Chemistry of Catalonia (IQAC-CSIC), C/Jordi Girona, 18-26, 08034, Barcelona, Spain; CIBER-BBN Networking Centre on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Spain.
CIBER-BBN Networking Centre on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Spain; Group of Dendrimers for Biomedical Applications, University of Alcalá (GDAB-UAH), Alcalá de Henares, Madrid, Spain.
Int J Pharm. 2015 Jan 15;478(1):113-123. doi: 10.1016/j.ijpharm.2014.11.031. Epub 2014 Nov 15.
The development of novel and efficient delivery systems is often the limiting step in fields such as antisense therapies. In this context, poly(d,l-lactide-co-glycolide) acid (PLGA) nanoparticles have been obtained by a versatile and simple technology based on nano-emulsion templating and low-energy emulsification methods, performed in mild conditions, providing good size control. O/W polymeric nano-emulsions were prepared by the phase inversion composition method at 25°C using the aqueous solution/polysorbate80/[4 wt% PLGA in ethyl acetate] system. Nano-emulsions formed at oil-to-surfactant (O/S) ratios between 10/90-90/10 and aqueous contents above 70 wt%. Nano-emulsion with 90 wt% of aqueous solution and O/S ratio of 70/30 was chosen for further studies, since they showed the appropriate characteristics to be used as nanoparticle template: hydrodynamic radii lower than 50 nm and enough kinetic stability. Nanoparticles, prepared from nano-emulsions by solvent evaporation, showed spherical shape, sizes about 40 nm, negative surface charges and high stability. The as-prepared nanoparticles were functionalized with carbosilane cationic dendrons through a carbodiimide-mediated reaction achieving positively charged surfaces. Antisense oligonucleotides were electrostatically attached to nanoparticles surface to perform gene-silencing studies. These complexes were non-haemolytic and non-cytotoxic at the concentrations required. The ability of the complexes to impart cellular uptake was also promising. Therefore, these novel nanoparticulate complexes might be considered as potential non-viral carriers in antisense therapy.
新型高效传递系统的发展通常是反义疗法等领域的限制步骤。在这种情况下,通过基于纳米乳液模板和低能量乳化方法的通用且简单的技术获得了聚(D,L-丙交酯-co-乙交酯)酸(PLGA)纳米粒子,该技术在温和的条件下进行,提供了良好的尺寸控制。O/W 聚合物纳米乳液是通过相转变组成法在 25°C 下使用水相/聚山梨酯 80/[4wt%PLGA 在乙酸乙酯中]系统制备的。在油-表面活性剂(O/S)比为 10/90-90/10 和水含量高于 70wt%的情况下形成纳米乳液。选择水相为 90wt%和 O/S 比为 70/30 的纳米乳液进行进一步研究,因为它们表现出适合用作纳米颗粒模板的适当特性:水动力学半径低于 50nm 且足够的动力学稳定性。通过溶剂蒸发从纳米乳液中制备的纳米颗粒呈球形,粒径约为 40nm,带负电荷,稳定性高。通过碳二亚胺介导的反应将制备的纳米颗粒用碳硅烷阳离子树状大分子功能化,实现表面正电荷。通过静电吸附将反义寡核苷酸附着到纳米颗粒表面以进行基因沉默研究。这些复合物在所需浓度下无溶血和细胞毒性。这些复合物赋予细胞摄取能力的能力也很有希望。因此,这些新型纳米颗粒复合物可被认为是反义治疗中的潜在非病毒载体。